🔎 Trials Near Me

Utama › Osteosarkoma › Michigan

Kajian klinikal Osteosarkoma di Michigan

6 kajian untuk Osteosarkoma sedang mencari peserta di lokasi di Michigan.

Bandar di Michigan

Teks kajian rasmi (Bahasa Inggeris)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • C S Mott Children's Hospital, Ann Arbor
Mengambil pesertaFasa 2
Umur 12 hingga 39 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT04616560

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Children's Hospital of Michigan/Wayne State University, Detroit
Mengambil pesertaFasa 1/2
Sehingga umur 30 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06541262

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  • C S Mott Children's Hospital, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Bronson Battle Creek, Battle Creek
  • dan 16 lagi
Mengambil pesertaFasa 3
Sehingga umur 50 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05235165

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • C S Mott Children's Hospital, Ann Arbor
Mengambil pesertaFasa 1/2
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Ascension Saint John Hospital, Detroit
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 18 Mei 2026 · NCT01790152

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

  • William Beaumont University Hospital, Royal Oak
Mengambil peserta
Umur 13 ke atas · Semua jantina · Dikemas kini 6 Feb 2026 · NCT06387485

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.